AI adoption in pharma can be slow, but failing to scale these new tools across your organization is a missed opportunity.

While AI-generated drugs grab headlines, the technology is making more of an impact doing less “glamorous” tasks.

Viz.ai is to enter a multi-year collaboration with Sanofi and Regeneron aimed at deploying and assessing an AI-powered ...

Experts predict growing pains as the life sciences sector moves to adapt to the EU AI Act. The EU Artificial Intelligence (AI ...

The pharmaceutical industry has long touted the promise of AI in slashing time and costs in the research and development ...

According to the GlobalData report ‘The State of the Biopharmaceutical Industry – 2025’, AI has the potential to significantly reduce pharmaceutical R&D costs by streamlining drug discovery, ...

Startup Persist AI, which launched a cloud lab to accelerate pharmaceutical formulation development, raised $12 million in a ...

Not unlike Regeneron's acquisition of 23andMe, Predictive Oncology's AI-driven breakthroughs reflect a broader transformation ...

SACRAMENTO, Calif., May 19, 2025 /PRNewswire/ -- Persist AI, a pioneer in AI-driven robotics for pharmaceutical formulation development and Chemistry, Manufacturing, and Controls (CMC), today ...

SACRAMENTO, Calif., May 19, 2025 /PRNewswire/ -- Persist AI, a pioneer in AI-driven robotics for pharmaceutical formulation development and Chemistry, Manufacturing, and Controls (CMC), today ...

Nandita Vijayasimha, Bengaluru Tuesday, May 20, 2025, 08:00 Hrs [IST] ...